According to the latest safety report by the U.S. Food and Drug Administration, a popular diabetes medicine called Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors are found to raise the risk of Fournier gangrene (FG), a flesh-eating infection of the genitals, also known as ...